From Name:
From Email:
To Name:
To Email:

Optional Message:

Olodaterol approved for COPD

from ASHP

FDA and Boehringer Ingelheim announced the approval of olodaterol oral inhalation spray as a long-term, once-daily maintenance bronchodilator to relieve airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063